Breaking News Instant updates and real-time market news.

NVCN

Neovasc

$1.52

0.01 (0.66%)

, EW

Edwards Lifesciences

$114.60

-0.35 (-0.30%)

10:46
06/16/17
06/16
10:46
06/16/17
10:46

Neovasc: German court partially finds in favor of Edwards Lifesciences in suit

Neovasc (NVCN) reported that the District Court in Munich, Germany has partially found in favor of Edwards Lifesciences Corporation (EW), in its case against Neovasc. In this case, CardiAQ had claimed ownership rights to one of Neovasc's European patent applications for its Tiara mitral valve replacement technology. The German court found CardiAQ had contributed in part to the invention of the Tiara and awarded to CardiAQ co-entitlement rights to the disputed Tiara European patent application. There are no monetary awards associated with this matter. Neovasc intends to appeal this decision. In a related matter, Neovasc is currently appealing the 2016 decision from the U.S District Court for the District of Massachusetts which among other things granted co-inventorship rights to CardiAQ on one of Neovasc's granted U.S. patent applications. This appeal is now before the United States Court of Appeals for the Federal Circuit in Washington D.C. An expedited appeal schedule has been set with all the briefings from both parties now submitted. The Company expects oral argument on its appeal in August 2017 and a ruling is expected to follow, prior to the end of 2017. Pending the outcome of the U.S. Court of Appeals, Neovasc, in consultation with its European and North American legal advisors, will vigorously defend its position that the case in Germany is without merit and will explore all options regarding the appellate process.

NVCN

Neovasc

$1.52

0.01 (0.66%)

EW

Edwards Lifesciences

$114.60

-0.35 (-0.30%)

  • 20

    Jun

  • 15

    Aug

NVCN Neovasc
$1.52

0.01 (0.66%)

04/05/17
LTCO
04/05/17
UPGRADE
Target $4
LTCO
Buy
Neovasc upgraded to Buy on Reducer and Tiara advancement at Ladenburg
As previously reported, Ladenburg analyst Jeffrey Cohen upgraded Neovasc to Buy from Neutral with a $4 price target. The analyst told investors he is encouraged by Reducer update combined with Tiara's pace of clinical work. He expects current litigation will conclude in 2H 2017 and that the current scenario of decision/liabilities represents a worse case scenario with potential upside from a reversal of decisions and/or liabilities.
04/05/17
LTCO
04/05/17
UPGRADE
LTCO
Buy
Neovasc upgraded to Buy from Neutral at Ladenburg
12/02/16
LEER
12/02/16
NO CHANGE
LEER
Outperform
Neovasc's Boston Scientific deal provides a reprieve, says Leerink
Leerink analyst Danielle Antalffy said Neovasc (NVCN) share are reacting positively to the announcement that Boston Scientific (BSX) is aquiring tissue manufacturing assets and a 15% stake on the company for $75M. The analyst said the deal significantly improves its ability to continue to operate regardless of the outcome of ongoing litigation and believes the likelihood that Neovasc can continue to operate has increased substantially. Antalffy rates Neovasc an Outperform.
EW Edwards Lifesciences
$114.60

-0.35 (-0.30%)

05/26/17
BOFA
05/26/17
NO CHANGE
Target $140
BOFA
Buy
Edwards Lifesciences price target raised to $140 from $120 at BofA/Merrill
BofA/Merrill analyst Bob Hopkins raised best large cap idea Edwards Lifescience's price target to $140 from $120 and reiterated his Buy rating The analyst thinks the Street is underestimating the strength in the US TAVR market and said 3-year average trend growth is the highest in years. Hopkins is also bullish on the new Ultra delivery system following favorable physician feedback.
05/23/17
MSCO
05/23/17
NO CHANGE
MSCO
Medtech Technology sector upgraded to Attractive from In-Line at Morgan Stanley
Morgan Stanley upgraded the Medtech Technology sector to Attractive saying structural fundamentals have improved and recent acceleration will likely continue, driving further multiple expansion.
05/17/17
RHCO
05/17/17
NO CHANGE
RHCO
Edwards Lifesciences data 'very strong, ' says SunTrust
SunTrust analyst Bruce Nudell says that the data presented on Edwards' self-expanding Centera valve was "very strong." The analyst thinks the company has a good chance to increase its market share in the category over time. He raised his price target on the stock to $130 from $120 and keeps a Buy rating.
05/17/17
ADAM
05/17/17
NO CHANGE
Target $150
ADAM
Buy
Edwards Lifesciences reiterated as a top large-cap pick at Canaccord
Canaccord analyst Jason Mills reiterated Edwards Lifesciences as a top large-cap pick, citing the robust clinical data on Centara presented at the EuroPCR, which reinforced his bullish thesis regarding the company's leadership in the most dynamic contemporary market in all of Med-Tech. Mills reiterated his Buy rating and raised his price target to $150 from $140 on Edwards Lifesciences shares.

TODAY'S FREE FLY STORIES

SLB

Schlumberger

09:29
01/22/18
01/22
09:29
01/22/18
09:29
Recommendations
Schlumberger analyst commentary  »

Schlumberger price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

09:28
01/22/18
01/22
09:28
01/22/18
09:28
Hot Stocks
Breaking Hot Stocks news story on Halliburton »

Halliburton says sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

HAL

Halliburton

09:27
01/22/18
01/22
09:27
01/22/18
09:27
Hot Stocks
Breaking Hot Stocks news story on Halliburton »

Halliburton…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

WP

Worldpay

09:27
01/22/18
01/22
09:27
01/22/18
09:27
Initiation
Worldpay initiated  »

Worldpay reinstated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

09:26
01/22/18
01/22
09:26
01/22/18
09:26
Hot Stocks
Halliburton says sees new effective tax rate approximately 21%-23% »

Says new tax rate a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

TXN

Texas Instruments

$116.83

0.42 (0.36%)

09:25
01/22/18
01/22
09:25
01/22/18
09:25
Recommendations
Texas Instruments analyst commentary  »

Texas Instruments price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

09:25
01/22/18
01/22
09:25
01/22/18
09:25
General news
IMF revised its global growth outlook higher, in part on U.S. tax cuts »

IMF revised its global…

PAYC

Paycom

, ALRM

Alarm.com

$38.73

-0.7 (-1.78%)

09:25
01/22/18
01/22
09:25
01/22/18
09:25
Conference/Events
Jefferies software analyst holds an analyst/industry conference call »

Software Analyst DiFucci…

PAYC

Paycom

ALRM

Alarm.com

$38.73

-0.7 (-1.78%)

CA

CA Technologies

$34.07

-0.12 (-0.35%)

RHT

Red Hat

ORCL

Oracle

SSNC

SS&C

$49.98

0.04 (0.08%)

VMW

VMware

CTXS

Citrix

$92.72

1.34 (1.47%)

MSFT

Microsoft

$90.00

-0.1 (-0.11%)

SYMC

Symantec

$27.46

0.21 (0.77%)

PANW

Palo Alto Networks

APTI

Apptio

$24.79

0.56 (2.31%)

CHKP

Check Point

$104.48

1.28 (1.24%)

NICE

Nice

$93.60

-0.23 (-0.25%)

SPLK

Splunk

$89.94

-1.49 (-1.63%)

RNG

RingCentral

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 30

    Jan

  • 31

    Jan

  • 31

    Jan

  • 31

    Jan

  • 31

    Jan

  • 05

    Feb

  • 06

    Feb

  • 06

    Feb

  • 06

    Feb

  • 07

    Feb

  • 07

    Feb

  • 12

    Feb

  • 26

    Feb

  • 27

    Feb

DCIX

Diana Containerships

$3.24

0.09 (2.86%)

09:23
01/22/18
01/22
09:23
01/22/18
09:23
Hot Stocks
Diana Containerships sells two post-Panamax container vessels for $22M »

Diana Containerships has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAA

CalAtlantic

, LEN

Lennar

09:23
01/22/18
01/22
09:23
01/22/18
09:23
Recommendations
CalAtlantic, Lennar analyst commentary  »

CalAtlantic price target…

CAA

CalAtlantic

LEN

Lennar

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJI

South Jersey Industries

09:21
01/22/18
01/22
09:21
01/22/18
09:21
Downgrade
South Jersey Industries rating change  »

South Jersey Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

KBH

KB Home

09:20
01/22/18
01/22
09:20
01/22/18
09:20
Recommendations
KB Home analyst commentary  »

KB Home price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

09:20
01/22/18
01/22
09:20
01/22/18
09:20
General news
U.S. Producer Sentiment Tailwinds Extend Into 2018: »

U.S. Producer Sentiment…

TOL

Toll Brothers

09:19
01/22/18
01/22
09:19
01/22/18
09:19
Recommendations
Toll Brothers analyst commentary  »

Toll Brothers price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYNN

Wynn Resorts

$179.64

4.16 (2.37%)

, HAL

Halliburton

09:19
01/22/18
01/22
09:19
01/22/18
09:19
Hot Stocks
On The Fly: Pre-market Movers »

UP AFTER EARNINGS: Wynn…

WYNN

Wynn Resorts

$179.64

4.16 (2.37%)

HAL

Halliburton

PETS

PetMed Express

$53.24

2.67 (5.28%)

OPB

Opus Bank

$28.70

0.05 (0.17%)

BCRX

BioCryst

$5.59

-0.09 (-1.58%)

IDRA

Idera Pharmaceuticals

$2.55

0.145 (6.03%)

ANF

Abercrombie & Fitch

AAPL

Apple

$178.46

-0.8 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 01

    Feb

CYTX

Cytori Therapeutics

$0.40

-0.0188 (-4.48%)

09:19
01/22/18
01/22
09:19
01/22/18
09:19
Hot Stocks
Cytori Therapeutics completes enrollment in Habeo trial for scleroderma »

Cytori Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBS

UBS

09:18
01/22/18
01/22
09:18
01/22/18
09:18
Periodicals
UBS to start moving jobs in early 2018 ahead of Brexit, Telegraph reports »

UBS will begin shifting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

09:18
01/22/18
01/22
09:18
01/22/18
09:18
Hot Stocks
Breaking Hot Stocks news story on Halliburton »

Halliburton says expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

PHM

PulteGroup

09:18
01/22/18
01/22
09:18
01/22/18
09:18
Recommendations
PulteGroup analyst commentary  »

PulteGroup price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

SPX

S&P 500

, VIX

Volatility Index S&P 500 Options

09:18
01/22/18
01/22
09:18
01/22/18
09:18
Options
Overnight activity included 111 trades in SPX and 29 trades in VIX »

111 trades were executed…

SPX

S&P 500

VIX

Volatility Index S&P 500 Options

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RF

Regions Financial

09:17
01/22/18
01/22
09:17
01/22/18
09:17
Upgrade
Regions Financial rating change  »

Regions Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHI

D.R. Horton

09:16
01/22/18
01/22
09:16
01/22/18
09:16
Recommendations
D.R. Horton analyst commentary  »

D.R. Horton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 31

    Jan

SDR

SandRidge Mississippian Trust II

09:16
01/22/18
01/22
09:16
01/22/18
09:16
Hot Stocks
SandRidge Mississippian Trust II receives NYSE notice on listing standards »

SandRidge Mississippian…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:15
01/22/18
01/22
09:15
01/22/18
09:15
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

HAL

Halliburton

09:14
01/22/18
01/22
09:14
01/22/18
09:14
Hot Stocks
Halliburton says expects improved utilization to drive margin growth »

Sees boosting frack…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.